Dental Pulp Exposure Clinical Trial
Official title:
The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy on CAP-1 Patients: A Randomised, Patient - and Observer-Blinded Multicenter Trial
CAP-2 Trial
Background: This trial is being done in conjunction with an ongoing clinical trial
investigating stepwise excavation versus final excavation on deep caries lesions (The CAP-1
trial). The investigators lack systematic knowledge concerning the treatment of the exposed
pulp and whether the capping of a pulp represents the same outcome as the partial removal of
an additional 1-1.5 mm of the pulp tissue (partial pulpotomy).
Aim: The aim of the CAP-2 trial is in a randomised clinical trial to investigate the effect
of direct pulp capping versus partial pulpotomy in patients who, from the beginning, have
received either a final excavation or a stepwise excavation and where this intervention has
led to the exposure of a vital pulp and/or the patient has not gained relief from tooth pain
after excavation and placement of a temporary restoration.
Patients: Patients include consecutive patients with deep caries who have been participating
in the CAP-1 trial, where the pulp exposure to a bleeding pulp is present and/or pain relief
has not been obtained.
Design: The CAP-2 trial is a randomised patient- and observer-blinded multicenter trial,
with two parallel intervention groups. Patients who fulfill the inclusion criteria will be
centrally bloc-randomised in the Copenhagen Trial Unit, Copenhagen DK, and stratified by age
and pain. The allocation ratio is 1:1.
The Interventions and Products: Patients are allocated for direct pulp capping or partial
pulpotomy. The patients will not be informed about the results of the randomisation, i.e.
the type of intervention. In both groups the patient receives a calcium hydroxide seal
covering the exposure and a glass ionomer restoration. The final resin restoration is placed
following 4 weeks.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02019563 -
MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial
|
Phase 2 | |
Completed |
NCT00812877 -
Pulp Capping With Two Different Agents
|
N/A | |
Not yet recruiting |
NCT04330768 -
Platelet Rich Fibrin(PRF) Injection for Treatment of Dental Pulp Exposure:Randomized Clinical Trial
|
N/A | |
Completed |
NCT02789423 -
Clinical & Radiographical Evaluation of the Effect of Dycal & Biodentine in DPC in Primary Teeth
|
N/A | |
Completed |
NCT01468480 -
Human Pulpal Response After Pulp Capping With Four Different Agents
|
Phase 2/Phase 3 | |
Completed |
NCT02487329 -
The Effect of Laser Combined With Pulp-capping Agents on Direct Pulp Capping
|
N/A | |
Completed |
NCT03631511 -
Histological Evaluation of Hard Tissue Formation After Direct Pulp Capping With RetroMTA
|
N/A | |
Completed |
NCT02492841 -
Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth
|
Phase 2/Phase 3 |